{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:50:31Z","timestamp":1790869831894,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10096-025-05145-1","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:44:49Z","timestamp":1745995489000},"page":"1763-1778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of antibiotic treatment on hemolytic uremic syndrome risk in Escherichia coli O157 infections: a comprehensive systematic review and meta-analysis"],"prefix":"10.1007","volume":"44","author":[{"given":"Patricia","family":"Sevilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altea","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana V.","family":"Nuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Camarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"12","key":"5145_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1056\/NEJM198303243081203","volume":"308","author":"LW Riley","year":"1983","unstructured":"Riley LW, Remis RS, Helgerson SD et al (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308(12):681\u2013685. https:\/\/doi.org\/10.1056\/NEJM198303243081203","journal-title":"N Engl J Med"},{"key":"5145_CR2","unstructured":"Ameer MA, Wasey A, Salen P (2024) Escherichia coli (e Coli 0157 H7). StatPearls"},{"key":"5145_CR3","unstructured":"Fatima R, Aziz M (2024) Enterohemorrhagic Escherichia coli. StatPearls"},{"issue":"5","key":"5145_CR4","doi-asserted-by":"publisher","first-page":"e39347","DOI":"10.7759\/cureus.39347","volume":"15","author":"SS Aldharman","year":"2023","unstructured":"Aldharman SS, Almutairi SM, Alharbi AA, Alyousef MA, Alzankrany KH, Althagafi MK et al (2023) The prevalence and incidence of hemolytic uremic syndrome: A systematic review. Cureus 15(5):e39347. https:\/\/doi.org\/10.7759\/cureus.39347","journal-title":"Cureus"},{"issue":"1","key":"5145_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/toxins15010010","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Thaker H, Wang C, Xu Z, Dong M (2022) Diagnosis and treatment for Shiga Toxin-Producing Escherichia coli associated hemolytic uremic syndrome. Toxins 15(1):10. https:\/\/doi.org\/10.3390\/toxins15010010","journal-title":"Toxins"},{"key":"5145_CR6","unstructured":"Bhandari J, Rout P, Sedhai YR (2024) Hemolytic Uremic Syndrome. StatPearls"},{"issue":"9","key":"5145_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-109-9-705","volume":"109","author":"PM Griffin","year":"1988","unstructured":"Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH et al (1988) Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med 109(9):705\u2013712. https:\/\/doi.org\/10.7326\/0003-4819-109-9-705","journal-title":"Ann Intern Med"},{"issue":"10","key":"5145_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/cid\/ciw101","volume":"62","author":"RK Mody","year":"2016","unstructured":"Mody RK, Griffin PM (2016) Editorial commentary: increasing evidence that certain antibiotics should be avoided for Shiga Toxin-Producing Escherichia coli infections: more data needed. Clin Infect Dis Off Publ Infect Dis Soc Am 62(10):1259\u20131261. https:\/\/doi.org\/10.1093\/cid\/ciw101","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"8","key":"5145_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jama.288.8.996","volume":"288","author":"N Safdar","year":"2002","unstructured":"Safdar N, Said A, Gangnon RE, Maki DG (2002) Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 288(8):996\u20131001. https:\/\/doi.org\/10.1001\/jama.288.8.996","journal-title":"JAMA"},{"issue":"10","key":"5145_CR10","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/cid\/ciw099","volume":"62","author":"SB Freedman","year":"2016","unstructured":"Freedman SB, Xie J, Neufeld MS et al (2016) Shiga Toxin-Producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: A Meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am 62(10):1251\u20131258. https:\/\/doi.org\/10.1093\/cid\/ciw099","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"5145_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"9","key":"5145_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73(9):712\u2013716. https:\/\/doi.org\/10.1046\/j.1445-2197.2003.02748.x","journal-title":"ANZ J Surg"},{"issue":"3","key":"5145_CR13","doi-asserted-by":"publisher","first-page":"e0118961","DOI":"10.1371\/journal.pone.0118961","volume":"10","author":"KP Allagh","year":"2015","unstructured":"Allagh KP, Shamanna BR, Murthy GVS, Ness AR, Doyle P, Neogi SB et al (2015) Birth prevalence of neural tube defects and orofacial clefts in India: a systematic review and meta-analysis. PLoS ONE 10(3):e0118961. https:\/\/doi.org\/10.1371\/journal.pone.0118961","journal-title":"PLoS ONE"},{"key":"5145_CR14","doi-asserted-by":"crossref","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (2019) Cochrane handbook for systematic reviews of interventions. Wiley","DOI":"10.1002\/9781119536604"},{"issue":"6","key":"5145_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.spinee.2024.02.019","volume":"24","author":"J Burgos","year":"2024","unstructured":"Burgos J, Hevia E, Sanpera I, Garc\u00eda V, de Santos Moreno MT, Mariscal G et al (2024) Elevated blood metal ion levels in patients undergoing instrumented spinal surgery: a systematic review and meta-analysis. Spine J Off J North Am Spine Soc 24(6):947\u2013960. https:\/\/doi.org\/10.1016\/j.spinee.2024.02.019","journal-title":"Spine J Off J North Am Spine Soc"},{"issue":"2","key":"5145_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","volume":"66","author":"GH Guyatt","year":"2013","unstructured":"Guyatt GH, Thorlund K, Oxman AD et al (2013) GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol 66(2):173\u2013183. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.08.001","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"5145_CR17","doi-asserted-by":"publisher","first-page":"e000465","DOI":"10.1136\/bmjpo-2019-000465","volume":"3","author":"N Adams","year":"2019","unstructured":"Adams N, Byrne L, Rose T et al (2019) Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study. BMJ Paediatr Open 3(1):e000465. https:\/\/doi.org\/10.1136\/bmjpo-2019-000465","journal-title":"BMJ Paediatr Open"},{"issue":"10","key":"5145_CR18","doi-asserted-by":"publisher","first-page":"e625","DOI":"10.1097\/PEC.0000000000001850","volume":"37","author":"A Balestracci","year":"2021","unstructured":"Balestracci A, Meni Battaglia L, Toledo I, Martin SM, Alvarado C (2021) Prodromal phase of hemolytic uremic syndrome related to Shiga Toxin-Producing Escherichia coli: the wasted time. Pediatr Emerg Care 37(10):e625\u2013e630. https:\/\/doi.org\/10.1097\/PEC.0000000000001850","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"5145_CR19","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1542\/peds.100.1.e12","volume":"100","author":"BP Bell","year":"1997","unstructured":"Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI (1997) Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100(1):E12. https:\/\/doi.org\/10.1542\/peds.100.1.e12","journal-title":"Pediatrics"},{"issue":"5","key":"5145_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/003693300204700505","volume":"47","author":"AM Cadwgan","year":"2002","unstructured":"Cadwgan AM, Laing RBS, Dargie L, Beadsworth M, Mackenzie AR, Douglas JG (2002) Three years experience of adults admitted to hospital in north-east Scotland with E. coli O157. Scott Med J 47(5):112\u2013114. https:\/\/doi.org\/10.1177\/003693300204700505","journal-title":"Scott Med J"},{"issue":"2","key":"5145_CR21","first-page":"85","volume":"42","author":"N Cimolai","year":"1994","unstructured":"Cimolai N, Basalyga S, Mah DG, Morrison BJ, Carter JE (1994) A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. Clin Nephrol 42(2):85\u201389","journal-title":"Clin Nephrol"},{"issue":"7","key":"5145_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1086\/322598","volume":"33","author":"S Dundas","year":"2001","unstructured":"Dundas S, Todd WT, Stewart AI, Murdoch PS, Chaudhuri AK, Hutchinson SJ (2001) The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis Off Publ Infect Dis Soc Am 33(7):923\u2013931. https:\/\/doi.org\/10.1086\/322598","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"5145_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jpeds.2016.09.013","volume":"180","author":"SB Freedman","year":"2017","unstructured":"Freedman SB, Eltorki M, Chui L et al (2017) Province-Wide review of pediatric Shiga Toxin-Producing Escherichia coli case management. J Pediatr 180:184\u2013190e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.013","journal-title":"J Pediatr"},{"issue":"3","key":"5145_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.11150\/kansenshogakuzasshi1970.72.266","volume":"72","author":"S Higami","year":"1998","unstructured":"Higami S, Nishimoto K, Kawamura T, Tsuruhara T, Isshiki G, Ookita A (1998) [Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 Enterocolitis in the Sakai outbreak]. Kansenshogaku Zasshi 72(3):266\u2013272. https:\/\/doi.org\/10.11150\/kansenshogakuzasshi1970.72.266","journal-title":"Kansenshogaku Zasshi"},{"issue":"6","key":"5145_CR25","first-page":"357","volume":"52","author":"K Ikeda","year":"1999","unstructured":"Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K (1999) Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin Nephrol 52(6):357\u2013362","journal-title":"Clin Nephrol"},{"issue":"1","key":"5145_CR26","doi-asserted-by":"publisher","first-page":"e009933","DOI":"10.1136\/bmjopen-2015-009933","volume":"6","author":"N Launders","year":"2016","unstructured":"Launders N, Byrne L, Jenkins C, Harker K, Charlett A, Adak GK (2016) Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009\u20132012. BMJ Open 6(1):e009933. https:\/\/doi.org\/10.1136\/bmjopen-2015-009933","journal-title":"BMJ Open"},{"issue":"9","key":"5145_CR27","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/microorganisms9091997","volume":"9","author":"RK Mody","year":"2021","unstructured":"Mody RK, Hoekstra RM, Scott MK et al (2021) Risk of hemolytic uremic syndrome related to treatment of Escherichia coli O157 infection with different antimicrobial classes. Microorganisms 9(9):1997. https:\/\/doi.org\/10.3390\/microorganisms9091997","journal-title":"Microorganisms"},{"issue":"2","key":"5145_CR28","doi-asserted-by":"publisher","first-page":"e0263349","DOI":"10.1371\/journal.pone.0263349","volume":"17","author":"S Myojin","year":"2022","unstructured":"Myojin S, Pak K, Sako M et al (2022) Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study. PLoS ONE 17(2):e0263349. https:\/\/doi.org\/10.1371\/journal.pone.0263349","journal-title":"PLoS ONE"},{"issue":"5","key":"5145_CR29","doi-asserted-by":"publisher","first-page":"442","DOI":"10.7883\/yoken.65.442","volume":"65","author":"K Ohnishi","year":"2012","unstructured":"Ohnishi K, Nakamura-Uchiyama F (2012) Does Levofloxacin induce hemolytic uremic syndrome in patients infected with verotoxin-producing Escherichia coli O157 infections? Jpn J Infect Dis 65(5):442\u2013443. https:\/\/doi.org\/10.7883\/yoken.65.442","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"5145_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jama.1989.03430030043031","volume":"262","author":"SM Ostroff","year":"1989","unstructured":"Ostroff SM, Kobayashi JM, Lewis JH (1989) Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA 262(3):355\u2013359","journal-title":"JAMA"},{"issue":"4","key":"5145_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/s0022-3476(05)81600-2","volume":"116","author":"AT Pavia","year":"1990","unstructured":"Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD et al (1990) Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr 116(4):544\u2013551. https:\/\/doi.org\/10.1016\/s0022-3476(05)81600-2","journal-title":"J Pediatr"},{"issue":"2","key":"5145_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0022-3476(05)81209-0","volume":"121","author":"F Proulx","year":"1992","unstructured":"Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L (1992) Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr 121(2):299\u2013303. https:\/\/doi.org\/10.1016\/s0022-3476(05)81209-0","journal-title":"J Pediatr"},{"issue":"10","key":"5145_CR33","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl L-B et al (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis Off Publ Infect Dis Soc Am 54(10):1413\u20131421. https:\/\/doi.org\/10.1093\/cid\/cis196","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"5145_CR34","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/515258","volume":"177","author":"L Slutsker","year":"1998","unstructured":"Slutsker L, Ries AA, Maloney K, Wells JG, Greene KD, Griffin PM (1998) A nationwide case-control study of Escherichia coli O157:H7 infection in the united States. J Infect Dis 177(4):962\u2013966. https:\/\/doi.org\/10.1086\/515258","journal-title":"J Infect Dis"},{"issue":"1","key":"5145_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","volume":"31","author":"KE Smith","year":"2012","unstructured":"Smith KE, Wilker PR, Reiter PL, Hedican EB, Bender JB, Hedberg CW (2012) Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J 31(1):37\u201341. https:\/\/doi.org\/10.1097\/INF.0b013e31823096a8","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"5145_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijantimicag.2015.08.006","volume":"46","author":"H Tajiri","year":"2015","unstructured":"Tajiri H, Nishi J, Ushijima K, Shimizu T, Ishige T, Shimizu M et al (2015) A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection. Int J Antimicrob Agents 46(5):586\u2013589. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.08.006","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"5145_CR37","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ijmm.2018.06.009","volume":"308","author":"GAM Tarr","year":"2018","unstructured":"Tarr GAM, Oltean HN, Phipps AI, Rabinowitz P, Tarr PI (2018) Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition. Int J Med Microbiol IJMM 308(7):921\u2013926. https:\/\/doi.org\/10.1016\/j.ijmm.2018.06.009","journal-title":"Int J Med Microbiol IJMM"},{"issue":"12","key":"5145_CR38","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.3201\/eid1112.0506077","volume":"11","author":"B Tserenpuntsag","year":"2005","unstructured":"Tserenpuntsag B, Chang H-G, Smith PF, Morse DL (2005) Hemolytic uremic syndrome risk and Escherichia coli O157:H7. Emerg Infect Dis 11(12):1955\u20131957. https:\/\/doi.org\/10.3201\/eid1112.0506077","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"5145_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/cid\/cis299","volume":"55","author":"CS Wong","year":"2012","unstructured":"Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR et al (2012) Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis Off Publ Infect Dis Soc Am 55(1):33\u201341. https:\/\/doi.org\/10.1093\/cid\/cis299","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"5","key":"5145_CR40","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s12223-021-00882-0","volume":"66","author":"A Rehman","year":"2021","unstructured":"Rehman A, Andleeb S, Ullah SR, Mustafa Z, Gul D, Mehmood K (2021) Antibiotic-mediated expression analysis of Shiga toxin 1 and 2 in multi-drug-resistant Shiga toxigenic Escherichia coli. Folia Microbiol (Praha) 66(5):809\u2013817. https:\/\/doi.org\/10.1007\/s12223-021-00882-0","journal-title":"Folia Microbiol (Praha)"},{"key":"5145_CR41","unstructured":"Assistance Publique - H\u00f4pitaux de Paris (2021) Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome. clinicaltrials.gov"},{"issue":"9","key":"5145_CR42","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1128\/aac.01783-09","volume":"54","author":"CM McGannon","year":"2010","unstructured":"McGannon CM, Fuller CA, Weiss AA (2010) Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob Agents Chemother 54(9):3790\u20133798. https:\/\/doi.org\/10.1128\/aac.01783-09","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05145-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05145-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05145-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:00:31Z","timestamp":1757163631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05145-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["5145"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05145-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}